{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:31:13Z","timestamp":1794411073139,"version":"4.9.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>An essential protein regulatory system in cells is the ubiquitin-proteasome pathway. The substrate is modified by the ubiquitin ligase system (E1-E2-E3) in this pathway, which is a dynamic protein bidirectional modification regulation system. Deubiquitinating enzymes (DUBs) are tasked with specifically hydrolyzing ubiquitin molecules from ubiquitin-linked proteins or precursor proteins and inversely regulating protein degradation, which in turn affects protein function. The ubiquitin-specific peptidase 32 (USP32) protein level is associated with cell cycle progression, proliferation, migration, invasion, and other cellular biological processes. It is an important member of the ubiquitin-specific protease family. It is thought that USP32, a unique enzyme that controls the ubiquitin process, is closely linked to the onset and progression of many cancers, including small cell lung cancer, gastric cancer, breast cancer, epithelial ovarian cancer, glioblastoma, gastrointestinal stromal tumor, acute myeloid leukemia, and pancreatic adenocarcinoma. In this review, we focus on the multiple mechanisms of USP32 in various tumor types and show that USP32 controls the stability of many distinct proteins. Therefore, USP32 is a key and promising therapeutic target for tumor therapy, which could provide important new insights and avenues for antitumor drug development. The therapeutic importance of USP32 in cancer treatment remains to be further proven. In conclusion, there are many options for the future direction of USP32 research.<\/jats:p>","DOI":"10.1038\/s41420-023-01629-1","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T13:02:42Z","timestamp":1694091762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target"],"prefix":"10.1038","volume":"9","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-8507","authenticated-orcid":false,"given":"Chunyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8243-8705","authenticated-orcid":false,"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"1629_CR1","volume":"10","author":"X-N Zhang","year":"2019","unstructured":"Zhang X-N, Cheng Q, Chen J, Lam AT, Lu Y, Dai Z, et al. A ribose-functionalized NAD+ with unexpected high activity and selectivity for protein poly-ADP-ribosylation. Nat Commun. 2019;10:4196.","journal-title":"Nat Commun"},{"key":"1629_CR2","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.7150\/ijbs.70955","volume":"18","author":"P Zhao","year":"2022","unstructured":"Zhao P, Yao R, Zhang Z, Zhu S, Li Y, Ren C, et al. Eukaryotic ribosome quality control system: a potential therapeutic target for human diseases. Int J Biol Sci. 2022;18:2497\u2013514.","journal-title":"Int J Biol Sci"},{"key":"1629_CR3","doi-asserted-by":"crossref","first-page":"2102991","DOI":"10.1002\/advs.202102991","volume":"8","author":"J Bae","year":"2021","unstructured":"Bae J, Kim H, Kim G, Song J, Kim H. Dendrimer\u2010like supramolecular assembly of proteins with a tunable size and valency through stepwise iterative growth. Adv Sci (Weinh). 2021;8:2102991.","journal-title":"Adv Sci (Weinh)"},{"key":"1629_CR4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2006.09.026","volume":"127","author":"JV Olsen","year":"2006","unstructured":"Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006;127:635\u201348.","journal-title":"Cell"},{"key":"1629_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-arplant-050718-100211","volume":"70","author":"AH Millar","year":"2019","unstructured":"Millar AH, Heazlewood JL, Giglione C, Holdsworth MJ, Bachmair A, Schulze WX. The scope, functions, and dynamics of posttranslational protein modifications. Annu Rev Plant Biol. 2019;70:119\u201351.","journal-title":"Annu Rev Plant Biol"},{"key":"1629_CR6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek KN, Komander D. Ubiquitin modifications. Cell Res. 2016;26:399\u2013422.","journal-title":"Cell Res"},{"key":"1629_CR7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tcb.2013.12.003","volume":"24","author":"G Kleiger","year":"2014","unstructured":"Kleiger G, Mayor T. Perilous journey: a tour of the ubiquitin-proteasome system. Trends Cell Biol. 2014;24:352\u20139.","journal-title":"Trends Cell Biol"},{"key":"1629_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbcan.2017.11.001","volume":"1869","author":"J Cheng","year":"2018","unstructured":"Cheng J, Guo J, Wang Z, North BJ, Tao K, Dai X, et al. Functional analysis of Cullin 3 E3 ligases in tumorigenesis. Biochim Biophys Acta Rev Cancer. 2018;1869:11\u201328.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1629_CR9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.molcel.2011.11.020","volume":"44","author":"RJ Tomko","year":"2011","unstructured":"Tomko RJ, Hochstrasser M. Incorporation of the Rpn12 subunit couples completion of proteasome regulatory particle lid assembly to lid-base joining. Mol Cell. 2011;44:907\u201317.","journal-title":"Mol Cell"},{"key":"1629_CR10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.molcel.2018.02.002","volume":"69","author":"K Baranes-Bachar","year":"2018","unstructured":"Baranes-Bachar K, Levy-Barda A, Oehler J, Reid DA, Soria-Bretones I, Voss TC, et al. The ubiquitin E3\/E4 ligase UBE4A adjusts protein ubiquitylation and accumulation at sites of dna damage, facilitating double-strand break repair. Mol Cell. 2018;69:866\u2013878.e7.","journal-title":"Mol Cell"},{"key":"1629_CR11","doi-asserted-by":"crossref","first-page":"190147","DOI":"10.1098\/rsob.190147","volume":"9","author":"AJ McClellan","year":"2019","unstructured":"McClellan AJ, Laugesen SH, Ellgaard L. Cellular functions and molecular mechanisms of non-lysine ubiquitination. Open Biol. 2019;9:190147.","journal-title":"Open Biol"},{"key":"1629_CR12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fchem.2019.00915","volume":"7","author":"G Dittmar","year":"2019","unstructured":"Dittmar G, Winklhofer KF. Linear ubiquitin chains: cellular functions and strategies for detection and quantification. Front Chem. 2019;7:915.","journal-title":"Front Chem"},{"key":"1629_CR13","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1111\/febs.14478","volume":"285","author":"LM Fennell","year":"2018","unstructured":"Fennell LM, Rahighi S, Ikeda F. Linear ubiquitin chain-binding domains. FEBS J. 2018;285:2746\u201361.","journal-title":"FEBS J"},{"key":"1629_CR14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41380-021-01233-8","volume":"27","author":"B Liu","year":"2022","unstructured":"Liu B, Ruan J, Chen M, Li Z, Manjengwa G, Schl\u00fcter D, et al. Deubiquitinating enzymes (DUBs): decipher underlying basis of neurodegenerative diseases. Mol Psychiatry. 2022;27:259\u201368.","journal-title":"Mol Psychiatry"},{"key":"1629_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/cr.2010.166","volume":"21","author":"EW Harhaj","year":"2011","unstructured":"Harhaj EW, Dixit VM. Deubiquitinases in the regulation of NF-\u03baB signaling. Cell Res. 2011;21:22\u201339.","journal-title":"Cell Res"},{"key":"1629_CR16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","volume":"20","author":"MJ Clague","year":"2019","unstructured":"Clague MJ, Urb\u00e9 S, Komander D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol. 2019;20:338\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1629_CR17","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/onc.2011.443","volume":"31","author":"JM Fraile","year":"2012","unstructured":"Fraile JM, Quesada V, Rodr\u00edguez D, Freije JMP, L\u00f3pez-Ot\u00edn C. Deubiquitinases in cancer: new functions and therapeutic options. Oncogene. 2012;31:2373\u201388.","journal-title":"Oncogene"},{"key":"1629_CR18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","volume":"10","author":"D Komander","year":"2009","unstructured":"Komander D, Clague MJ, Urb\u00e9 S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10:550\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1629_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-019-0522-0","volume":"26","author":"M-J Young","year":"2019","unstructured":"Young M-J, Hsu K-C, Lin TE, Chang W-C, Hung J-J. The role of ubiquitin-specific peptidases in cancer progression. J Biomed Sci. 2019;26:42.","journal-title":"J Biomed Sci"},{"key":"1629_CR20","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.3390\/ijms24043219","volume":"24","author":"H Kitamura","year":"2023","unstructured":"Kitamura H. Ubiquitin-specific proteases (USPs) and metabolic disorders. Int J Mol Sci. 2023;24:3219.","journal-title":"Int J Mol Sci"},{"key":"1629_CR21","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.3390\/ijms23073705","volume":"23","author":"O Buneeva","year":"2022","unstructured":"Buneeva O, Medvedev A. Atypical ubiquitination and Parkinson\u2019s disease. Int J Mol Sci. 2022;23:3705.","journal-title":"Int J Mol Sci"},{"key":"1629_CR22","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1073\/pnas.0437015100","volume":"100","author":"CA Paulding","year":"2003","unstructured":"Paulding CA, Ruvolo M, Haber DA. The Tre2 (USP6) oncogene is a hominoid-specific gene. Proc Natl Acad Sci USA. 2003;100:2507\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1629_CR23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00335-010-9268-4","volume":"21","author":"S Akhavantabasi","year":"2010","unstructured":"Akhavantabasi S, Akman HB, Sapmaz A, Keller J, Petty EM, Erson AE. USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers. Mamm Genome. 2010;21:388\u201397.","journal-title":"Mamm Genome"},{"key":"1629_CR24","doi-asserted-by":"crossref","first-page":"e12343","DOI":"10.1111\/cpr.12343","volume":"50","author":"W Hu","year":"2017","unstructured":"Hu W, Wei H, Li K, Li P, Lin J, Feng R. Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer. Cell Prolif. 2017;50:e12343.","journal-title":"Cell Prolif"},{"key":"1629_CR25","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.7150\/ijbs.43117","volume":"16","author":"N Dou","year":"2020","unstructured":"Dou N, Hu Q, Li L, Wu Q, Li Y, Gao Y. USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2. Int J Biol Sci. 2020;16:1648\u201357.","journal-title":"Int J Biol Sci"},{"key":"1629_CR26","first-page":"222","volume":"25","author":"J Li","year":"2023","unstructured":"Li J, Bo Y, Ding B, Wang L. Understanding the regulatory role of USP32 and SHMT2 in the progression of gastric cancer. Cell J. 2023;25:222\u20138.","journal-title":"Cell J"},{"key":"1629_CR27","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.21037\/tcr.2019.08.30","volume":"8","author":"C Liu","year":"2019","unstructured":"Liu C, Chen Z, Fang M, Qiao Y. MicroRNA let-7a inhibits proliferation of breast cancer cell by downregulating USP32 expression. Transl Cancer Res. 2019;8:1763\u201371.","journal-title":"Transl Cancer Res"},{"key":"1629_CR28","doi-asserted-by":"crossref","first-page":"9752","DOI":"10.7150\/thno.63806","volume":"11","author":"AP Chandrasekaran","year":"2021","unstructured":"Chandrasekaran AP, Kaushal K, Park C-H, Kim K-S, Ramakrishna S. USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2. Theranostics. 2021;11:9752\u201371.","journal-title":"Theranostics"},{"key":"1629_CR29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2021.03.049","volume":"552","author":"A Nakae","year":"2021","unstructured":"Nakae A, Kodama M, Okamoto T, Tokunaga M, Shimura H, Hashimoto K, et al. Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1. Biochem Biophys Res Commun. 2021;552:120\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1629_CR30","volume":"12","author":"S Chen","year":"2022","unstructured":"Chen S, Chen X, Li Z, Mao J, Jiang W, Zhu Z, et al. Identification of ubiquitin-specific protease 32 as an oncogene in glioblastoma and the underlying mechanisms. Sci Rep. 2022;12:6445.","journal-title":"Sci Rep"},{"key":"1629_CR31","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41388-023-02600-1","volume":"42","author":"C Li","year":"2023","unstructured":"Li C, Gao Z, Cui Z, Liu Z, Bian Y, Sun H, et al. Deubiquitylation of Rab35 by USP32 promotes the transmission of imatinib resistance by enhancing exosome secretion in gastrointestinal stromal tumours. Oncogene. 2023;42:894\u2013910.","journal-title":"Oncogene"},{"key":"1629_CR32","first-page":"6109052","volume":"2022","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhou D, Kong Y, Yang Q, Ding Y, Wang W. USPs in pancreatic ductal adenocarcinoma: a comprehensive bioinformatic analysis of expression, prognostic significance, and immune infiltration. Biomed Res Int. 2022;2022:6109052.","journal-title":"Biomed Res Int"},{"key":"1629_CR33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3724\/abbs.2023037","volume":"55","author":"H Zhang","year":"2023","unstructured":"Zhang H, Tao Y, Ding X, Wang Y, Wang X. Roles of the hsa_circ_0013880\/USP32\/Rap1b axis in the proliferation and apoptosis of acute myeloid leukemia cells. Acta Biochim Biophys Sin (Shanghai). 2023;55:382\u201393.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1629_CR34","doi-asserted-by":"crossref","first-page":"111653","DOI":"10.1016\/j.celrep.2022.111653","volume":"41","author":"A Hertel","year":"2022","unstructured":"Hertel A, Alves LM, Dutz H, Tascher G, Bonn F, Kaulich M, et al. USP32-regulated LAMTOR1 ubiquitination impacts mTORC1 activation and autophagy induction. Cell Rep. 2022;41:111653.","journal-title":"Cell Rep"},{"key":"1629_CR35","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09437-x","volume":"10","author":"A Sapmaz","year":"2019","unstructured":"Sapmaz A, Berlin I, Bos E, Wijdeven RH, Janssen H, Konietzny R, et al. USP32 regulates late endosomal transport and recycling through deubiquitylation of Rab7. Nat Commun. 2019;10:1454.","journal-title":"Nat Commun"},{"key":"1629_CR36","doi-asserted-by":"crossref","first-page":"W420","DOI":"10.1093\/nar\/gkac373","volume":"50","author":"Y Xie","year":"2022","unstructured":"Xie Y, Li H, Luo X, Li H, Gao Q, Zhang L, et al. IBS 2.0: an upgraded illustrator for the visualization of biological sequences. Nucleic Acids Res. 2022;50:W420\u2013W426.","journal-title":"Nucleic Acids Res"},{"key":"1629_CR37","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Ye C, Tian T, Jiang Q, Zhao P, Wang X, et al. The emerging role of ubiquitin-specific protease 20 in tumorigenesis and cancer therapeutics. Cell Death Dis. 2022;13:434.","journal-title":"Cell Death Dis"},{"key":"1629_CR38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/cr.2014.20","volume":"24","author":"W Yue","year":"2014","unstructured":"Yue W, Chen Z, Liu H, Yan C, Chen M, Feng D, et al. A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30. Cell Res. 2014;24:482\u201396.","journal-title":"Cell Res"},{"key":"1629_CR39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"1629_CR40","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","volume":"50","author":"M Varadi","year":"2022","unstructured":"Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022;50:D439\u2013D444.","journal-title":"Nucleic Acids Res"},{"key":"1629_CR41","doi-asserted-by":"crossref","first-page":"e20988","DOI":"10.1371\/journal.pone.0020988","volume":"6","author":"N Pankratz","year":"2011","unstructured":"Pankratz N, Dumitriu A, Hetrick KN, Sun M, Latourelle JC, Wilk JB, et al. Copy number variation in familial Parkinson disease. PLoS ONE. 2011;6:e20988.","journal-title":"PLoS ONE"},{"key":"1629_CR42","doi-asserted-by":"crossref","first-page":"e0170535","DOI":"10.1371\/journal.pone.0170535","volume":"12","author":"S Jeong","year":"2017","unstructured":"Jeong S, Oh JM, Oh K-H, Kim I-W. Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients. PLoS ONE. 2017;12:e0170535.","journal-title":"PLoS ONE"},{"key":"1629_CR43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10495398.2021.1932520","volume":"34","author":"A Kour","year":"2021","unstructured":"Kour A, Deb SM, Nayee N, Niranjan SK, Raina VS, Mukherjee A, et al. Novel insights into genome-wide associations in Bos indicus reveal genetic linkages between fertility and growth. Anim Biotechnol. 2021;34:39\u201355.","journal-title":"Anim Biotechnol"},{"key":"1629_CR44","doi-asserted-by":"crossref","first-page":"e72879","DOI":"10.7554\/eLife.72879","volume":"11","author":"LM Doherty","year":"2022","unstructured":"Doherty LM, Mills CE, Boswell SA, Liu X, Hoyt CT, Gyori B, et al. Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes. Elife. 2022;11:e72879.","journal-title":"Elife"},{"key":"1629_CR45","first-page":"733","volume":"7","author":"T Nakamura","year":"1992","unstructured":"Nakamura T, Hillova J, Mariage-Samson R, Onno M, Huebner K, Cannizzaro LA, et al. A novel transcriptional unit of the tre oncogene widely expressed in human cancer cells. Oncogene. 1992;7:733\u201341.","journal-title":"Oncogene"},{"key":"1629_CR46","first-page":"247","volume":"38","author":"M Legrand","year":"2023","unstructured":"Legrand M, Jourdan M-L, de Pinieux G. Histopathogenesis of bone- and soft-tissue tumor spectrum with USP6 gene rearrangement: multiple partners involved in the tissue repair process. Histol Histopathol. 2023;38:247\u201360.","journal-title":"Histol Histopathol"},{"key":"1629_CR47","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/1066896920938878","volume":"28","author":"LS Hiemcke-Jiwa","year":"2020","unstructured":"Hiemcke-Jiwa LS, van Gorp JM, Fisher C, Creytens D, van Diest PJ, Flucke U. USP6-associated neoplasms: a rapidly expanding family of lesions. Int J Surg Pathol. 2020;28:816\u201325.","journal-title":"Int J Surg Pathol"},{"key":"1629_CR48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.gene.2016.04.037","volume":"588","author":"Y Ma","year":"2016","unstructured":"Ma Y, Tian S, He S, Chen Q, Wang Z, Xiao X, et al. The mechanism of action of FXR1P-related miR-19b-3p in SH-SY5Y. Gene. 2016;588:62\u201368.","journal-title":"Gene"},{"key":"1629_CR49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.fsi.2020.06.016","volume":"104","author":"Y-L Sun","year":"2020","unstructured":"Sun Y-L, Guan X-L, Zhang P, Li M-F, Zhang J, Sun L. Pol-miR-363-3p plays a significant role in the immune defense of Japanese flounder Paralichthys olivaceus against bacterial and viral infection. Fish Shellfish Immunol. 2020;104:439\u201346.","journal-title":"Fish Shellfish Immunol"},{"key":"1629_CR50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Prim. 2021;7:3.","journal-title":"Nat Rev Dis Prim"},{"key":"1629_CR51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.semcancer.2022.03.006","volume":"86","author":"X Yin","year":"2022","unstructured":"Yin X, Li Y, Wang H, Jia T, Wang E, Luo Y, et al. Small cell lung cancer transformation: from pathogenesis to treatment. Semin Cancer Biol. 2022;86:595\u2013606.","journal-title":"Semin Cancer Biol"},{"key":"1629_CR52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-019-0736-3","volume":"12","author":"S Yang","year":"2019","unstructured":"Yang S, Zhang Z, Wang Q. Emerging therapies for small cell lung cancer. J Hematol Oncol. 2019;12:47.","journal-title":"J Hematol Oncol"},{"key":"1629_CR53","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3390\/ijms22073418","volume":"22","author":"L Seeneevassen","year":"2021","unstructured":"Seeneevassen L, Bess\u00e8de E, M\u00e9graud F, Lehours P, Dubus P, Varon C. Gastric cancer: advances in carcinogenesis research and new therapeutic strategies. Int J Mol Sci. 2021;22:3418.","journal-title":"Int J Mol Sci"},{"key":"1629_CR54","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3322\/caac.21657","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA A Cancer J Clin. 2021;71:264\u201379.","journal-title":"CA A Cancer J Clin"},{"key":"1629_CR55","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.semcancer.2021.12.004","volume":"86","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Semin Cancer Biol. 2022;86:566\u201382.","journal-title":"Semin Cancer Biol"},{"key":"1629_CR56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73:17\u201348.","journal-title":"Cancer J Clin"},{"key":"1629_CR57","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.3390\/ijms23179617","volume":"23","author":"A Kawiak","year":"2022","unstructured":"Kawiak A. Molecular research and treatment of breast cancer. Int J Mol Sci. 2022;23:9617.","journal-title":"Int J Mol Sci"},{"key":"1629_CR58","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1158\/0008-5472.CAN-08-4596","volume":"69","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Martens JWM, Yu JX, Jiang J, Sieuwerts AM, Smid M, et al. Copy number alterations that predict metastatic capability of human breast cancer. Cancer Res. 2009;69:3795\u2013801.","journal-title":"Cancer Res"},{"key":"1629_CR59","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1604","volume":"8","author":"A Grigoriadis","year":"2006","unstructured":"Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, et al. Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res. 2006;8:R56.","journal-title":"Breast Cancer Res"},{"key":"1629_CR60","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393:1240\u201353.","journal-title":"Lancet"},{"key":"1629_CR61","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41388-022-02181-5","volume":"41","author":"NE James","year":"2022","unstructured":"James NE, Woodman M, Ribeiro JR. Prognostic immunologic signatures in epithelial ovarian cancer. Oncogene. 2022;41:1389\u201396.","journal-title":"Oncogene"},{"key":"1629_CR62","doi-asserted-by":"crossref","first-page":"m3773","DOI":"10.1136\/bmj.m3773","volume":"371","author":"L Kuroki","year":"2020","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;371:m3773.","journal-title":"BMJ"},{"key":"1629_CR63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","volume":"9","author":"A Bikfalvi","year":"2023","unstructured":"Bikfalvi A, da Costa CA, Avril T, Barnier J-V, Bauchet L, Brisson L, et al. Challenges in glioblastoma research: focus on the tumor microenvironment. Trends Cancer. 2023;9:9\u201327.","journal-title":"Trends Cancer"},{"key":"1629_CR64","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s13402-022-00684-7","volume":"45","author":"C Boccellato","year":"2022","unstructured":"Boccellato C, Rehm M. Glioblastoma, from disease understanding towards optimal cell-based in vitro models. Cell Oncol (Dordr). 2022;45:527\u201341.","journal-title":"Cell Oncol (Dordr)"},{"key":"1629_CR65","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","volume":"41","author":"L Rong","year":"2022","unstructured":"Rong L, Li N, Zhang Z. Emerging therapies for glioblastoma: current state and future directions. J Exp Clin Cancer Res. 2022;41:142.","journal-title":"J Exp Clin Cancer Res"},{"key":"1629_CR66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-021-00254-5","volume":"7","author":"J-Y Blay","year":"2021","unstructured":"Blay J-Y, Kang Y-K, Nishida T, Von Mehren M. Gastrointestinal stromal tumours. Nat Rev Dis Prim. 2021;7:22.","journal-title":"Nat Rev Dis Prim"},{"key":"1629_CR67","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(20)30335-1","volume":"21","author":"V Nguyen","year":"2020","unstructured":"Nguyen V, Banerjee S, Sicklick JK. Moving gastrointestinal stromal tumours towards truly personalised precision therapy. Lancet Oncol. 2020;21:865\u20137.","journal-title":"Lancet Oncol"},{"key":"1629_CR68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canep.2015.10.031","volume":"40","author":"K S\u00f8reide","year":"2016","unstructured":"S\u00f8reide K, Sandvik OM, S\u00f8reide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39\u201346.","journal-title":"Cancer Epidemiol"},{"key":"1629_CR69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1083\/jcb.200911018","volume":"189","author":"C Hsu","year":"2010","unstructured":"Hsu C, Morohashi Y, Yoshimura S-I, Manrique-Hoyos N, Jung S, Lauterbach MA, et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol. 2010;189:223\u201332.","journal-title":"J Cell Biol"},{"key":"1629_CR70","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","volume":"392","author":"NJ Short","year":"2018","unstructured":"Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392:593\u2013606.","journal-title":"Lancet"},{"key":"1629_CR71","doi-asserted-by":"crossref","first-page":"n2026","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375:n2026.","journal-title":"BMJ"},{"key":"1629_CR72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.6004\/jnccn.2021.0002","volume":"19","author":"DA Pollyea","year":"2021","unstructured":"Pollyea DA, Bixby D, Perl A, Bhatt VR, Altman JK, Appelbaum FR, et al. NCCN guidelines insights: acute myeloid leukemia, version 2. 2021. J Natl Compr Canc Netw. 2021;19:16\u201327.","journal-title":"J Natl Compr Canc Netw"},{"key":"1629_CR73","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk\u2010stratification, and management. Am J Hematol. 2023;98:502\u201326.","journal-title":"Am J Hematol"},{"key":"1629_CR74","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13046-021-02008-3","volume":"40","author":"Y Liao","year":"2021","unstructured":"Liao Y, Shao Z, Liu Y, Xia X, Deng Y, Yu C, et al. USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2021;40:201.","journal-title":"J Exp Clin Cancer Res"},{"key":"1629_CR75","doi-asserted-by":"crossref","first-page":"nwab212","DOI":"10.1093\/nsr\/nwab212","volume":"9","author":"J-T Li","year":"2022","unstructured":"Li J-T, Li K-Y, Su Y, Shen Y, Lei M-Z, Zhang F, et al. Diet high in branched-chain amino acid promotes PDAC development by USP1-mediated BCAT2 stabilization. Natl Sci Rev. 2022;9:nwab212.","journal-title":"Natl Sci Rev"},{"key":"1629_CR76","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/cas.14375","volume":"111","author":"S-Z Cui","year":"2020","unstructured":"Cui S-Z, Lei Z-Y, Guan T-P, Fan L-L, Li Y-Q, Geng X-Y, et al. Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy. Cancer Sci. 2020;111:1567\u201381.","journal-title":"Cancer Sci"},{"key":"1629_CR77","doi-asserted-by":"crossref","first-page":"106092","DOI":"10.1016\/j.biocel.2021.106092","volume":"141","author":"J Xu","year":"2021","unstructured":"Xu J, Li B, Song W, Cao L, Zhu C, Lin S. Tumor suppressor functions of miRNA-375 in nasopharyngeal carcinoma through inhibition of ubiquitin-specific protease 1 expression. Int J Biochem Cell Biol. 2021;141:106092.","journal-title":"Int J Biochem Cell Biol"},{"key":"1629_CR78","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.3390\/cancers12113090","volume":"12","author":"A Mussell","year":"2020","unstructured":"Mussell A, Shen H, Chen Y, Mastri M, Eng KH, Bshara W, et al. USP1 regulates TAZ protein stability through ubiquitin modifications in breast cancer. Cancers (Basel). 2020;12:3090.","journal-title":"Cancers (Basel)"},{"key":"1629_CR79","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1038\/s41388-022-02275-0","volume":"41","author":"Y Tu","year":"2022","unstructured":"Tu Y, Xu L, Xu J, Bao Z, Tian W, Ye Y, et al. Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-\u03b2 signaling. Oncogene. 2022;41:2597\u2013608.","journal-title":"Oncogene"},{"key":"1629_CR80","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1080\/15548627.2022.2044651","volume":"18","author":"W Xiao","year":"2022","unstructured":"Xiao W, Wang J, Wang X, Cai S, Guo Y, Ye L, et al. Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression. Autophagy. 2022;18:2615\u201335.","journal-title":"Autophagy"},{"key":"1629_CR81","first-page":"1525216","volume":"2022","author":"L Zhu","year":"2022","unstructured":"Zhu L, Chen Z, Guo T, Chen W, Zhao L, Guo L, et al. USP2 inhibits lung cancer pathogenesis by reducing ARID2 protein degradation via ubiquitination. Biomed Res Int. 2022;2022:1525216.","journal-title":"Biomed Res Int"},{"key":"1629_CR82","volume":"21","author":"K Shi","year":"2021","unstructured":"Shi K, Zhang JZ, Yang L, Li N-N, Yue Y, Du X-H, et al. Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma. BMC Cancer. 2021;21:1196.","journal-title":"BMC Cancer"},{"key":"1629_CR83","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41374-022-00836-1","volume":"102","author":"R-P Liang","year":"2022","unstructured":"Liang R-P, Zhang X-X, Zhao J, Zhu R-T, Wang W-J, Lu Q-W, et al. Ubiquitin-specific protease 3 facilitates cell proliferation by deubiquitinating pyruvate kinase L\/R in gallbladder cancer. Lab Investig. 2022;102:1367\u201376.","journal-title":"Lab Investig"},{"key":"1629_CR84","first-page":"3143","volume":"24","author":"X-H Liao","year":"2020","unstructured":"Liao X-H, Wang Y, Zhong B, Zhu S-Y. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4. Eur Rev Med Pharm Sci. 2020;24:3143\u201351.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"1629_CR85","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/ijc.32523","volume":"146","author":"N Geng","year":"2020","unstructured":"Geng N, Li Y, Zhang W, Wang F, Wang X, Jin Z, et al. A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis. Int J Cancer. 2020;146:1139\u201351.","journal-title":"Int J Cancer"},{"key":"1629_CR86","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/cancers12061582","volume":"12","author":"F Li","year":"2020","unstructured":"Li F, Hu Q, He T, Xu J, Yi Y, Xie S, et al. The deubiquitinase USP4 stabilizes twist1 protein to promote lung cancer cell stemness. Cancers (Basel). 2020;12:1582.","journal-title":"Cancers (Basel)"},{"key":"1629_CR87","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/s41388-021-01712-w","volume":"40","author":"BB Cheung","year":"2021","unstructured":"Cheung BB, Kleynhans A, Mittra R, Kim PY, Holien JK, Nagy Z, et al. A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma. Oncogene. 2021;40:2367\u201381.","journal-title":"Oncogene"},{"key":"1629_CR88","volume":"12","author":"J Pan","year":"2021","unstructured":"Pan J, Qiao Y, Chen C, Zang H, Zhang X, Qi F, et al. USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1. Cell Death Dis. 2021;12:1051.","journal-title":"Cell Death Dis"},{"key":"1629_CR89","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/jcp.30686","volume":"237","author":"W Huang","year":"2022","unstructured":"Huang W, Liu X, Zhang Y, Deng M, Li G, Chen G, et al. USP5 promotes breast cancer cell proliferation and metastasis by stabilizing HIF2\u03b1. J Cell Physiol. 2022;237:2211\u20139.","journal-title":"J Cell Physiol"},{"key":"1629_CR90","doi-asserted-by":"crossref","first-page":"720307","DOI":"10.3389\/fphar.2021.720307","volume":"12","author":"G Li","year":"2021","unstructured":"Li G, Yang T, Chen Y, Bao J, Wu D, Hu X, et al. USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1. Front Pharm. 2021;12:720307.","journal-title":"Front Pharm"},{"key":"1629_CR91","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1158\/0008-5472.CAN-20-1458","volume":"81","author":"IC Henrich","year":"2021","unstructured":"Henrich IC, Jain K, Young R, Quick L, Lindsay JM, Park DH, et al. Ubiquitin-specific protease 6 functions as a tumor suppressor in ewing sarcoma through immune activation. Cancer Res. 2021;81:2171\u201383.","journal-title":"Cancer Res"},{"key":"1629_CR92","volume":"13","author":"H-B Park","year":"2022","unstructured":"Park H-B, Hwang S, Baek K-H. USP7 regulates the ERK1\/2 signaling pathway through deubiquitinating Raf-1 in lung adenocarcinoma. Cell Death Dis. 2022;13:698.","journal-title":"Cell Death Dis"},{"key":"1629_CR93","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.apsb.2020.11.005","volume":"11","author":"Z Wang","year":"2021","unstructured":"Wang Z, Kang W, Li O, Qi F, Wang J, You Y, et al. Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing. Acta Pharm Sin B. 2021;11:694\u2013707.","journal-title":"Acta Pharm Sin B"},{"key":"1629_CR94","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1038\/s41388-022-02486-5","volume":"41","author":"G Saha","year":"2022","unstructured":"Saha G, Sarkar S, Mohanta PS, Kumar K, Chakrabarti S, Basu M, et al. USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma. Oncogene. 2022;41:5061\u201375.","journal-title":"Oncogene"},{"key":"1629_CR95","doi-asserted-by":"crossref","first-page":"215760","DOI":"10.1016\/j.canlet.2022.215760","volume":"542","author":"L Li","year":"2022","unstructured":"Li L, Liu Y, Zhao Y, Feng R, Li Y, Yu X, et al. Deubiquitinase USP8 increases ID1 stability and promotes esophageal squamous cell carcinoma tumorigenesis. Cancer Lett. 2022;542:215760.","journal-title":"Cancer Lett"},{"key":"1629_CR96","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Peng D, Liu Y, Zhang Q, Liu B, Deng Y, et al. Usp8 promotes tumor cell migration through activating the JNK pathway. Cell Death Dis. 2022;13:286.","journal-title":"Cell Death Dis"},{"key":"1629_CR97","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s11658-022-00343-7","volume":"27","author":"Y Huang","year":"2022","unstructured":"Huang Y, Xia L, Tan X, Zhang J, Zeng W, Tan B, et al. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR\/PD-L1\/USP8 axis. Cell Mol Biol Lett. 2022;27:43.","journal-title":"Cell Mol Biol Lett"},{"key":"1629_CR98","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41416-021-01421-x","volume":"125","author":"P Sulkshane","year":"2021","unstructured":"Sulkshane P, Pawar SN, Waghole R, Pawar SS, Rajput P, Uthale A, et al. Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers. Br J Cancer. 2021;125:547\u201360.","journal-title":"Br J Cancer"},{"key":"1629_CR99","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12929-021-00738-2","volume":"28","author":"W Chen","year":"2021","unstructured":"Chen W, Song J, Liu S, Tang B, Shen L, Zhu J, et al. USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1B\u03b2 via deubiquitinating EGLN3. J Biomed Sci. 2021;28:44.","journal-title":"J Biomed Sci"},{"key":"1629_CR100","volume":"21","author":"R Yang","year":"2022","unstructured":"Yang R, Chen H, Xing L, Wang B, Hu M, Ou X, et al. Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10. Mol Cancer. 2022;21:88.","journal-title":"Mol Cancer"},{"key":"1629_CR101","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1158\/0008-5472.CAN-19-2388","volume":"80","author":"H Zhu","year":"2020","unstructured":"Zhu H, Yan F, Yuan T, Qian M, Zhou T, Dai X, et al. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP\/TAZ. Cancer Res. 2020;80:2204\u201316.","journal-title":"Cancer Res"},{"key":"1629_CR102","volume":"14","author":"W Qiu","year":"2023","unstructured":"Qiu W, Xiao Z, Yang Y, Jiang L, Song S, Qi X, et al. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma. Cell Death Dis. 2023;14:207.","journal-title":"Cell Death Dis"},{"key":"1629_CR103","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.7150\/ijbs.71327","volume":"18","author":"L Li","year":"2022","unstructured":"Li L, Deng T, Zhang L, Wang Y, Zhou Y, Liu Y, et al. ERK-mediated cytoplasmic retention of USP11 contributes to breast cancer cell proliferation by stabilizing cytoplasmic p21. Int J Biol Sci. 2022;18:2568\u201382.","journal-title":"Int J Biol Sci"},{"key":"1629_CR104","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41388-021-02167-9","volume":"41","author":"H Li","year":"2022","unstructured":"Li H, Roy M, Liang L, Cao W, Hu B, Li Y, et al. Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1. Oncogene. 2022;41:1298\u2013308.","journal-title":"Oncogene"},{"key":"1629_CR105","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41388-021-01679-8","volume":"40","author":"EL Morgan","year":"2021","unstructured":"Morgan EL, Patterson MR, Barba-Moreno D, Scarth JA, Wilson A, Macdonald A. The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer. Oncogene. 2021;40:2112\u201329.","journal-title":"Oncogene"},{"key":"1629_CR106","doi-asserted-by":"crossref","first-page":"e2119854119","DOI":"10.1073\/pnas.2119854119","volume":"119","author":"H Xie","year":"2022","unstructured":"Xie H, Zhou J, Liu X, Xu Y, Hepperla AJ, Simon JM, et al. USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer. Proc Natl Acad Sci USA. 2022;119:e2119854119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1629_CR107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41418-022-01040-w","volume":"30","author":"C Zhao","year":"2023","unstructured":"Zhao C, Gong J, Bai Y, Yin T, Zhou M, Pan S, et al. A self-amplifying USP14-TAZ loop drives the progression and liver metastasis of pancreatic ductal adenocarcinoma. Cell Death Differ. 2023;30:1\u201315.","journal-title":"Cell Death Differ"},{"key":"1629_CR108","volume":"14","author":"X-H Du","year":"2023","unstructured":"Du X-H, Ke S-B, Liang X-Y, Gao J, Xie X-X, Qi L-Z, et al. USP14 promotes colorectal cancer progression by targeting JNK for stabilization. Cell Death Dis. 2023;14:56.","journal-title":"Cell Death Dis"},{"key":"1629_CR109","volume":"13","author":"M-J Kim","year":"2022","unstructured":"Kim M-J, Min Y, Jeong S-K, Son J, Kim JY, Lee JS, et al. USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction. Cell Death Dis. 2022;13:348.","journal-title":"Cell Death Dis"},{"key":"1629_CR110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13046-021-01843-8","volume":"40","author":"J Ge","year":"2021","unstructured":"Ge J, Yu W, Li J, Ma H, Wang P, Zhou Y, et al. USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc. J Exp Clin Cancer Res. 2021;40:59.","journal-title":"J Exp Clin Cancer Res"},{"key":"1629_CR111","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.canlet.2021.12.018","volume":"527","author":"X Li","year":"2022","unstructured":"Li X, Liu Z, Xia C, Yan K, Fang Z, Fan Y. SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC. Cancer Lett. 2022;527:150\u201363.","journal-title":"Cancer Lett"},{"key":"1629_CR112","doi-asserted-by":"crossref","first-page":"19273","DOI":"10.18632\/aging.103760","volume":"12","author":"L Feng","year":"2020","unstructured":"Feng L, Wang K, Tang P, Chen S, Liu T, Lei J, et al. Deubiquitinase USP18 promotes the progression of pancreatic cancer via enhancing the Notch1-c-Myc axis. Aging (Albany NY). 2020;12:19273\u201392.","journal-title":"Aging (Albany NY)"},{"key":"1629_CR113","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-021-00318-x","volume":"10","author":"FA Rossi","year":"2021","unstructured":"Rossi FA, Enriqu\u00e9 Steinberg JH, Calvo Roitberg EH, Joshi MU, Pandey A, Abba MC, et al. USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer. Oncogenesis. 2021;10:28.","journal-title":"Oncogenesis"},{"key":"1629_CR114","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1101\/gad.339804.120","volume":"34","author":"W Li","year":"2020","unstructured":"Li W, Shen M, Jiang Y-Z, Zhang R, Zheng H, Wei Y, et al. Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2. Genes Dev. 2020;34:1310\u20135.","journal-title":"Genes Dev"},{"key":"1629_CR115","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Chen Z, Tang Q, Wang Z, Lu J, You Y, et al. USP21 promotes self-renewal and tumorigenicity of mesenchymal glioblastoma stem cells by deubiquitinating and stabilizing FOXD1. Cell Death Dis. 2022;13:712.","journal-title":"Cell Death Dis"},{"key":"1629_CR116","volume":"12","author":"Y Tian","year":"2021","unstructured":"Tian Y, Tang B, Wang C, Wang Y, Mao J, Yao Y, et al. Operative ubiquitin-specific protease 22 deubiquitination confers a more invasive phenotype to cholangiocarcinoma. Cell Death Dis. 2021;12:678.","journal-title":"Cell Death Dis"},{"key":"1629_CR117","volume":"14","author":"K Zeng","year":"2023","unstructured":"Zeng K, Xie W, Wang C, Wang S, Liu W, Su Y, et al. USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma. Cell Death Dis. 2023;14:194.","journal-title":"Cell Death Dis"},{"key":"1629_CR118","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1038\/s41418-020-0568-2","volume":"27","author":"S Wang","year":"2020","unstructured":"Wang S, Zhong X, Wang C, Luo H, Lin L, Sun H, et al. USP22 positively modulates ER\u03b1 action via its deubiquitinase activity in breast cancer. Cell Death Differ. 2020;27:3131\u201345.","journal-title":"Cell Death Differ"},{"key":"1629_CR119","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.7150\/ijbs.54442","volume":"17","author":"H He","year":"2021","unstructured":"He H, Yi L, Zhang B, Yan B, Xiao M, Ren J, et al. USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway. Int J Biol Sci. 2021;17:2417\u201329.","journal-title":"Int J Biol Sci"},{"key":"1629_CR120","volume":"13","author":"JK Nelson","year":"2022","unstructured":"Nelson JK, Thin MZ, Evan T, Howell S, Wu M, Almeida B, et al. USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Nat Commun. 2022;13:2070.","journal-title":"Nat Commun"},{"key":"1629_CR121","volume":"13","author":"J Tang","year":"2022","unstructured":"Tang J, Luo Y, Xiao L. USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ. Cell Death Dis. 2022;13:326.","journal-title":"Cell Death Dis"},{"key":"1629_CR122","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00018-021-04118-9","volume":"79","author":"T Zou","year":"2022","unstructured":"Zou T, Wang Y, Dong L, Che T, Zhao H, Yan X, et al. Stabilization of SETD3 by deubiquitinase USP27 enhances cell proliferation and hepatocellular carcinoma progression. Cell Mol Life Sci. 2022;79:70.","journal-title":"Cell Mol Life Sci"},{"key":"1629_CR123","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Xu Z, Li Q, Feng Q, Zheng C, Du Y, et al. USP28 facilitates pancreatic cancer progression through activation of Wnt\/\u03b2-catenin pathway via stabilising FOXM1. Cell Death Dis. 2021;12:887.","journal-title":"Cell Death Dis"},{"key":"1629_CR124","volume":"10","author":"R Gao","year":"2021","unstructured":"Gao R, Buechel D, Kalathur RKR, Morini MF, Coto-Llerena M, Ercan C, et al. USP29-mediated HIF1\u03b1 stabilization is associated with Sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis. Oncogenesis. 2021;10:52.","journal-title":"Oncogenesis"},{"key":"1629_CR125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s11658-022-00407-8","volume":"27","author":"X Zhang","year":"2022","unstructured":"Zhang X, Han Y, Liu S, Guo B, Xu S, He Y, et al. MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30. Cell Mol Biol Lett. 2022;27:107.","journal-title":"Cell Mol Biol Lett"},{"key":"1629_CR126","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/s41418-019-0473-8","volume":"27","author":"F Guo","year":"2020","unstructured":"Guo F, Zhang C, Wang F, Zhang W, Shi X, Zhu Y, et al. Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer. Cell Death Differ. 2020;27:1938\u201351.","journal-title":"Cell Death Differ"},{"key":"1629_CR127","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2147\/OTT.S228857","volume":"13","author":"C Lin","year":"2020","unstructured":"Lin C, Xia J, Gu Z, Meng Y, Gao D, Wei S. Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11. Onco Targets Ther. 2020;13:1471\u201380.","journal-title":"Onco Targets Ther"},{"key":"1629_CR128","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41374-021-00725-z","volume":"102","author":"C Liu","year":"2022","unstructured":"Liu C, Chen Z, Ding X, Qiao Y, Li B. Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer. Lab Investig. 2022;102:524\u201333.","journal-title":"Lab Investig"},{"key":"1629_CR129","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Luo J, Xiao Z, Zang Y, Li X, Zhou Y, et al. USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP. Cell Death Dis. 2022;13:1021.","journal-title":"Cell Death Dis"},{"key":"1629_CR130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.7150\/thno.47800","volume":"11","author":"L Wu","year":"2021","unstructured":"Wu L, Zhao N, Zhou Z, Chen J, Han S, Zhang X, et al. PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1. Theranostics. 2021;11:700\u201314.","journal-title":"Theranostics"},{"key":"1629_CR131","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-020-0234-z","volume":"9","author":"W Zhan","year":"2020","unstructured":"Zhan W, Liao X, Liu J, Tian T, Yu L, Li R. USP38 regulates the stemness and chemoresistance of human colorectal cancer via regulation of HDAC3. Oncogenesis. 2020;9:48.","journal-title":"Oncogenesis"},{"key":"1629_CR132","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/s41418-021-00754-7","volume":"28","author":"X Li","year":"2021","unstructured":"Li X, Yuan J, Song C, Lei Y, Xu J, Zhang G, et al. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma. Cell Death Differ. 2021;28:2315\u201332.","journal-title":"Cell Death Differ"},{"key":"1629_CR133","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3390\/ijms24021693","volume":"24","author":"J-Y Yoon","year":"2023","unstructured":"Yoon J-Y, Seo S-U, Woo S-M, Kwon T-K. USP41 enhances epithelial-mesenchymal transition of breast cancer cells through snail stabilization. Int J Mol Sci. 2023;24:1693.","journal-title":"Int J Mol Sci"},{"key":"1629_CR134","volume":"13","author":"Y Xue","year":"2022","unstructured":"Xue Y, Li M, Hu J, Song Y, Guo W, Miao C, et al. Cav2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilization. Cell Death Dis. 2022;13:812.","journal-title":"Cell Death Dis"},{"key":"1629_CR135","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhao Y, Yang X, Ren X, Huang S, Gong S, et al. USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. Nat Commun. 2022;13:501.","journal-title":"Nat Commun"},{"key":"1629_CR136","doi-asserted-by":"crossref","first-page":"e2203423","DOI":"10.1002\/advs.202203423","volume":"10","author":"L Liu","year":"2023","unstructured":"Liu L, Chen C, Liu P, Li J, Pang Z, Zhu J, et al. MYH10 combines with MYH9 to recruit USP45 by deubiquitinating snail and promotes serous ovarian cancer carcinogenesis, progression, and cisplatin resistance. Adv Sci. 2023;10:e2203423.","journal-title":"Adv Sci"},{"key":"1629_CR137","doi-asserted-by":"crossref","first-page":"112188","DOI":"10.1016\/j.yexcr.2020.112188","volume":"395","author":"M Tian","year":"2020","unstructured":"Tian M, Zhu R, Ding F, Liu Z. Ubiquitin-specific peptidase 46 promotes tumor metastasis through stabilizing ENO1 in human esophageal squamous cell carcinoma. Exp Cell Res. 2020;395:112188.","journal-title":"Exp Cell Res"},{"key":"1629_CR138","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s13238-019-00674-w","volume":"11","author":"B Pan","year":"2020","unstructured":"Pan B, Yang Y, Li J, Wang Y, Fang C, Yu F-X, et al. USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer. Protein Cell. 2020;11:138\u201343.","journal-title":"Protein Cell"},{"key":"1629_CR139","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1158\/0008-5472.CAN-20-4163","volume":"81","author":"L Du","year":"2021","unstructured":"Du L, Li Y, Kang M, Feng M, Ren Y, Dai H, et al. USP48 Is upregulated by Mettl14 to attenuate hepatocellular carcinoma via regulating SIRT6 Stabilization. Cancer Res. 2021;81:3822\u201334.","journal-title":"Cancer Res"},{"key":"1629_CR140","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41388-022-02267-0","volume":"41","author":"Z Liu","year":"2022","unstructured":"Liu Z, Li J, Ding Y, Ma M, Chen J, Lei W, et al. USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer. Oncogene. 2022;41:2555\u201370.","journal-title":"Oncogene"},{"key":"1629_CR141","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41417-021-00420-7","volume":"29","author":"J Li","year":"2022","unstructured":"Li J, Xiao X, Wang H, Wang W, Ou Y, Wang Z, et al. CDK4\/6-USP51 axis regulates lung adenocarcinoma metastasis through ZEB1. Cancer Gene Ther. 2022;29:1181\u201392.","journal-title":"Cancer Gene Ther"},{"key":"1629_CR142","volume":"11","author":"Y Yao","year":"2022","unstructured":"Yao Y, Ma W, Guo Y, Liu Y, Xia P, Wu X, et al. USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. Oncogenesis. 2022;11:31.","journal-title":"Oncogenesis"},{"key":"1629_CR143","doi-asserted-by":"crossref","first-page":"105745","DOI":"10.1016\/j.isci.2022.105745","volume":"26","author":"C Zhang","year":"2023","unstructured":"Zhang C, Ma X, Wei G, Zhu X, Hu P, Chen X, et al. Centrosomal protein 120 promotes centrosome amplification and gastric cancer progression via USP54-mediated deubiquitination of PLK4. iScience. 2023;26:105745.","journal-title":"iScience"},{"key":"1629_CR144","doi-asserted-by":"crossref","first-page":"215586","DOI":"10.1016\/j.canlet.2022.215586","volume":"532","author":"L Wang","year":"2022","unstructured":"Wang L, Lin Y, Zhou X, Chen Y, Li X, Luo W, et al. CYLD deficiency enhances metabolic reprogramming and tumor progression in nasopharyngeal carcinoma via PFKFB3. Cancer Lett. 2022;532:215586.","journal-title":"Cancer Lett"},{"key":"1629_CR145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.canlet.2021.10.032","volume":"525","author":"S Haq","year":"2022","unstructured":"Haq S, Sarodaya N, Karapurkar JK, Suresh B, Jo JK, Singh V, et al. CYLD destabilizes NoxO1 protein by promoting ubiquitination and regulates prostate cancer progression. Cancer Lett. 2022;525:146\u201357.","journal-title":"Cancer Lett"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01629-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01629-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01629-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T23:05:05Z","timestamp":1700607905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-023-01629-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":145,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1629"],"URL":"https:\/\/doi.org\/10.1038\/s41420-023-01629-1","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}